Matthew Trass
Advertisement
Articles by Matthew Trass
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
3
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
4
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
5